Halberd Corporation (HALB)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. William A. Hartman | President, CEO & Chairman | -- | -- | 1942 |
| Mr. John S. Borza AVS, MBA, PE | COO & Director | -- | -- | 1954 |
| Ms. Heidi H. Carl | Director & Accounting Director | -- | -- | 1971 |
| Dr. Mitchell S. Felder M.D. | CTO & Member of the Scientific Advisory Board | -- | -- | 1954 |
| Dr. Patricio F. Reyes FAAN, M.D. | Chief Mechanical Officer & Member of the Scientific Advisory Board | -- | -- | 1947 |
Halberd Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
January 3, 2023 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)
November 9, 2022 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
September 1, 2022 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
August 15, 2022 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission